GSK Investigational Site

Monroe, Wisconsin 53566

0 studies enrolling now · 2 studies all time

What they study most

Measles-Mumps-Rubella, Measles-Mumps-Rubella Vaccine, Measles; Mumps; Rubella

Studies at this site

• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age — Completed
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age — Completed